Leaderboards/cancer therapeutics and mechanisms

cancer therapeutics and mechanisms

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Lei Wang
Southern University of Science and Technology
99
2
Wen Zhou
Southern University of Science and Technology
90
3
Antonio Cuevas-Navarro
Memorial Sloan Kettering Cancer Center
80
4
Piro Lito
Memorial Sloan Kettering Cancer Center
70
5
Monica Nesselbush
Stanford University
60
6
Xiaojing Yin
Second Military Medical University
40
7
Xiaolan Deng
City Of Hope National Medical Center
20
8
Jianjun Chen
City of Hope
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Xiangqin Meng
Institute of Biophysics
99
2
Jingwen Liu
Chengdu University of Traditional Chinese Medicine
90
3
Lingfeng Chen
Wenzhou Medical University
80
4
He Jiang
Central South University
70
5
Xinlu Han
Fudan University
50
6
Jing Zhang
Sichuan University
40
7
Stefania Morganti
Broad Institute
20
8
Xiaoyu Zhao
University of California San Diego
10

Emerging Leaders Papers

1
Structural basis for FGF hormone signalling
Nature|2023
115 cit.
2
Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer
Proceedings of the National Academy of Sciences|2024
38 cit.
3
A highly selective inhibitor of discoidin domain receptor‐1 (DDR1‐IN‐1) protects corneal epithelial cells from YAP/ACSL4‐mediated ferroptosis in dry eye
British Journal of Pharmacology|2024
9 cit.
4
UQCRC1 is a Key Pathogenic Determinant and Potential Therapeutic Target for Cognitive Impairment in Alzheimer’s Disease
Molecular Neurobiology|2025
2 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Hiroshi Maeda
Kumamoto University
99
2
Saul H. Rosenberg
Abbott Fund
90
3
Antoni Ribas
University of Colorado Cancer Center
80
4
Feng Cong
Novartis (Switzerland)
70
5
Steven Langston
Millennium Engineering and Integration (United States)
60
6
Ian MacLachlan
Arbutus Biopharma (Canada)
50
7
Stuart L. Schreiber
Broad Institute
40
8
Brent R. Stockwell
Columbia University
30
9
Andrew J. Armstrong
Cornell University
20
10
William R. Sellers
Novartis Foundation
10

All-Time Leaders Papers

1
Pembrolizumab versus Ipilimumab in Advanced Melanoma
New England Journal of Medicine|2015
5.8k cit.
2
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
New England Journal of Medicine|2016
3.1k cit.
3
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Nature|2010
2.5k cit.
4
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
Proceedings of the National Academy of Sciences|2016
2.2k cit.
5
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
New England Journal of Medicine|2014
2k cit.
6
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Cell Reports|2017
1.9k cit.
7
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
JAMA|2016
1.1k cit.
8
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis
Nature Communications|2019
859 cit.
9
Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma
Journal of Clinical Oncology|2013
813 cit.
10
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
Molecular Cancer Research|2011
650 cit.

Reagents for cancer therapeutics and mechanisms

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

USP8 (D18F6) Rabbit Monoclonal Antibody

Cited in 8 papers
#11832$161
View Evidence →Cell Signaling Technology

DTX3L (D5F2J) Rabbit Monoclonal Antibody

Cited in 8 papers
#14795$161
View Evidence →Cell Signaling Technology

LAMP1 (D4O1S) Mouse Monoclonal Antibody

Cited in 8 papers
#15665$152
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

COL3A1 Antibody

Cited in 9 papers
#30565$317
View Evidence →Cell Signaling Technology

CD45RO (UCHL1) Mouse Monoclonal Antibody

Cited in 9 papers
#55618$167
View Evidence →Cell Signaling Technology

Dystrophin (E4F3S) Rabbit Monoclonal Antibody

Cited in 9 papers
#47759$189
View Evidence →